Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
- Understand how the S-ICD is implanted, and how the arrhythmia algorithm and the S-ICD signal discriminate arrhythmias to deliver appropriate therapy and avoid inappropriate therapy.- Understand the morbidity benefits of subcutaneous ICD therapy- Understand which pt population cannot benefit from subcutaneous ICD - Appreciate effectiveness of the subcutaneous ICD to terminate ventricular arrhythmias- Appreciate subcutaneous ICD performance in different patient populations and disease states
- How to identify & screen patients appropriately for the subcutaneous ICD - How to implant the S-ICD- How to avoid pitfalls that diminish it's proper function- How to avoid complications- How to manage inappropriate shocks
Lucas Boersma, Pier Lambiase and Alessandro Capucci
The EHRA Webinars are designed to help you improve your daily practice!
The format includes a case based presentation, online assessment and live discussions with the two key opinion leaders who will give you some useful tips for your daily clinical practice.
- ESC guidelines- EHRA Key Reference Library - Weiss R, Knight BP, Gold MR et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 2013, 27;128(9):944-53.- Lambiase PD, Barr C, Theuns DA et al. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry. Eur Heart J 2014;35(25):1657-65.- Kooiman KM, Knops RE, Olde NL, Wilde AA, de G, Jr. Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management. Heart Rhythm 2014 March;11(3):426-34.
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903, Sophia Antipolis, FR
This programme is supported by Boston Scientific in the form of unrestricted educational grants. The scientific programme has not been influenced in any way by its sponsor.
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.